Science & Enterprise subscription

Follow us on Twitter

  • In one of its first actions, the Biden administration rejoined the United States in the World Health Organization,… https://t.co/gpHTTr70DP
    about 13 hours ago
  • New post on Science and Enterprise: U.S. Rejoins WHO, Participates in Int’l Vaccine Project https://t.co/bBUZr5UzSg #Science #Business
    about 13 hours ago
  • A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower ris… https://t.co/EPYrP8wElE
    about 17 hours ago
  • New post on Science and Enterprise: Antibodies Prevent Covid-19 Symptoms in Long-Term Care https://t.co/sePqojZMVd #Science #Business
    about 17 hours ago
  • Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
    about 1 day ago

Please share Science & Enterprise

US Govt to Buy 1.25M Regeneron Covid-19 Therapies

SARS-Cov-2 virus

The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies

Infographic – Countries Making Covid-19 Vaccines

Chart: Covid-19 vaccine sites

The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges. . . . → Read More: Infographic – Countries Making Covid-19 Vaccines

CureVac, Bayer Partner on Covid-19 Vaccine Supply

Syringe in hand

Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine. . . . → Read More: CureVac, Bayer Partner on Covid-19 Vaccine Supply

Trial OKed for Rare Disease Gene Therapy

Nerve cells illustration

A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy

Essay – Enlist U.S. Retailers for Vaccine Distribution

A promising solution for vaccine distribution is staring policy-makers in the face, on street corners and shopping centers across the U.S., retail chain stores. . . . → Read More: Essay – Enlist U.S. Retailers for Vaccine Distribution

Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant

Robin Shattock

A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin. . . . → Read More: Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant

Challenge Seeks Sustainable Chicken, Fish Alternatives

D.C. fish market

A new challenge competition from XPrize is looking for alternatives to chicken and fish that look and taste like the real thing, but are friendlier to the planet. . . . → Read More: Challenge Seeks Sustainable Chicken, Fish Alternatives

Biotech Manufacturing, Distribution Company Underway

Vaccine vials

A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway

Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Inspecting lung X-rays

Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Start-Up Gains Drug Nanoparticle Manufacturing Tech

Small bubbles

A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles. . . . → Read More: Start-Up Gains Drug Nanoparticle Manufacturing Tech